1. FDA approves Lilly/Boehringer triple combo diabetes drug Trijardy XR — Pfizer misses Q4 earnings forecasts and drops early-stage programs — How insulin pricing became a top issue in the 2020 Democratic race — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Regenesis Biomedical

Anonymous board for Regenesis Biomedical


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    2
    Views:
    3,666
  2. Anonymous
    Replies:
    1
    Views:
    4,287
  3. Anonymous
    Replies:
    0
    Views:
    2,885
  4. Anonymous
    Replies:
    0
    Views:
    3,835

Thread Display Options

Loading...